Skip to main content

Bicycle Therapeutics Insider Trades

+1.43 (+4.81 %)
(As of 05/14/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume50,994 shs
Average Volume160,848 shs
Market Capitalization$749.19 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling Activity

Insider Ownership Percentage: 26.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,454,644.72

Insider Buying and Selling by Quarter

Bicycle Therapeutics (NASDAQ BCYC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/6/2021Kevin LeeCEOSell1,716$32.14$55,152.24256,450  
5/4/2021Kevin LeeCEOSell897$32.03$28,730.91258,125  
4/30/2021Kevin LeeCEOSell58,919$30.86$1,818,240.34277,229  
4/28/2021Kevin LeeCEOSell22,495$31.08$699,144.60277,229  
4/26/2021Kevin LeeCEOSell18,611$31.28$582,152.08273,345  
4/8/2021Pierre LegaultDirectorSell24,838$31.71$787,612.9824,838  
4/5/2021Pierre LegaultDirectorSell162$31.07$5,033.34162  
3/31/2021Nicholas KeenInsiderSell10,000$30.00$300,000.0028,321  
3/17/2021Pierre LegaultDirectorSell7,784$29.00$225,736.007,784  
3/15/2021Nicholas KeenInsiderSell217$28.00$6,076.0038,821  
3/12/2021Nicholas KeenInsiderSell9,783$28.50$278,815.5038,821  
3/12/2021Pierre LegaultDirectorSell2,216$29.00$64,264.002,216  
1/19/2021Kevin LeeCEOSell5,000$29.26$146,300.00260,556  
1/19/2021Lee KalowskiCFOSell15,000$30.00$450,000.0015,000  
1/15/2021Kevin LeeCEOSell10,000$26.01$260,100.00270,085  
12/1/2020Lee KalowskiCFOSell7,500$22.50$168,750.007,500  
11/27/2020Lee KalowskiCFOSell530$20.00$10,600.00530  
11/25/2020Lee KalowskiCFOSell9,781$20.07$196,304.6717,189  
11/23/2020Lee KalowskiCFOSell17,189$19.83$340,857.8717,189  
7/14/2020Plc GlaxosmithklineMajor ShareholderSell1,597$19.27$30,774.19  
5/28/2019Deborah HarlandDirectorBuy385,714$14.00$5,399,996.00  
5/28/2019Life Sciences Fund V Lp SvMajor ShareholderBuy385,715$14.00$5,400,010.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/15/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.